Wu Jun

Chief Physician

The personalized treatment of thoracic tumors such as lung cancer and esophageal cancer, has accumulated certain experience in minimally invasive surgery of thoracic tumors, especially in the prevention, diagnosis and treatment of thoracic surgical complications.

Introduction of the expert

Chief Physician, expert in the International Department, associate professor, masters supervisor, and other high-level talents in Hainan Province. Graduated from Harbin Medical University and later stayed for masters degree studies at the same university, pursuing a doctoral degree at China Medical University. Successively served as resident physician, attending physician, and Deputy Chief Physician at the Affiliated Tumor Hospital of Harbin Medical University. With over ten years of experience in thoracic surgery, clinical research, and teaching, he focuses on personalized treatment of thoracic tumors such as lung cancer and esophageal cancer. He has accumulated considerable experience in minimally invasive thoracic surgery, particularly in the prevention, diagnosis, and treatment of thoracic surgical complications. He strives to adopt the most advanced and scientific treatment methods in the field and provides diagnostic and therapeutic services to patients. Since the establishment of the department, he has successfully completed challenging surgeries such as thoracoscopic three-incision esophagectomy combined with three-field lymph node dissection, single-port thoracoscopic lobectomy and segmentectomy, thoracoscopic sleeve resection of the lung, and total thymectomy under thoracoscope. Director Wu Jun has in-depth research in minimally invasive thoracic surgery techniques. Currently, the department has developed minimally invasive thoracic surgery techniques including thoracoscopic lobectomy, segmentectomy, esophagectomy, resection of esophageal leiomyoma, thoracic duct ligation, diaphragmatic hernia repair, paraspinal abscess incision and drainage, lung volume reduction surgery, pulmonary bulla resection, sympathectomy, thymoma resection, lung biopsy, pleural biopsy, mediastinal biopsy, Heller myotomy, mediastinal cyst resection, pulmonary wedge resection, neurogenic tumor resection, pleurodesis, pericardial fenestration, and lymph node biopsy.

Medical specialty

The personalized treatment of thoracic tumors such as lung cancer and esophageal cancer, has accumulated certain experience in minimally invasive surgery of thoracic tumors, especially in the prevention, diagnosis and treatment of thoracic surgical complications.

Academic association appointment

I. Member of the Lung Cancer Professional Committee of the Chinese Anti-Cancer Association

II. Member of the First Small Cell Special Committee of the Chinese Anti-Cancer Association

III. Vice Chairman of the Fifth Committee of the Thoracic and Cardiovascular Surgery Specialty Committee of the Hainan Provincial Medical Association

IV. Executive Committee Member of the Second Committee of the Thoracic Surgeons Branch of the Hainan Provincial Medical Doctor Association

V. Standing Committee Member of the First Artificial Intelligence Professional Committee of the Hainan Provincial Anti-Cancer Association

VI. Standing Committee Member of the Liquid Biopsy Professional Committee of the China Lung Cancer Prevention and Treatment Alliance

VII. Member of the Lung Cancer Medical Education Committee of the China Medical Education Association

VIII. Member of the Palliative Care Subcommittee of the Beijing Cancer Prevention and Treatment Research Association

IX. Member of the First Council of the Hainan Provincial Cancer Prevention and Control Association

X. Standing Committee Member of the First Committee of the Tumor Immunology and Precision Therapy Professional Committee of the Hainan Provincial Cancer Prevention and Treatment Association

XI. Eleven, Standing Committee Member of the MDT Professional Committee of the Hainan Provincial Cancer Prevention and Treatment Association

XII. Member of the Thoracic Surgery Quality Control Center of Hainan Province (2021)

XIII. Member of the Fourth Committee of the Oncology Specialty Committee of the Hainan Provincial Medical Association

XIV. Member of the First Committee of the Integrative Rehabilitation Specialty for Esophageal Cancer of the Chinese Anti-Cancer Association

XV. Executive member of the First Mediastinal Tumor Integrated Rehabilitation Professional Committee of the Chinese Anti-Cancer Association

XVI. Chairman of the First Committee of the Lung Cancer Professional Committee of the Hainan Provincial Cancer Prevention and Control Association

XVII. Member of the Expert Committee of the Medical Quality Control Center for Thoracic Surgery in Hainan Province

Papers and works

1.A polysaccharide from Armillaria mellea exhibits strong in vitro anticancer activity viaapoptosis-involved mechanisms. (the first author)
2.High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic inpatients with non-smallcelllungcancer. (the first author)
3.Fibroblast activation protein-αpromotes cancer cell proliferation and invasion via extracellular and intracellular signaling mechanisms. (the fifth author)